MDGEF (Medigene AG) Interest Expense : $-0.58 Mil (TTM As of Jun. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Medigene AG Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Medigene AG's interest expense for the six months ended in Jun. 2024 was $ -0.01 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2024 was $-0.58 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Medigene AG's Operating Income for the six months ended in Jun. 2024 was $ -7.15 Mil. Medigene AG's Interest Expense for the six months ended in Jun. 2024 was $ -0.01 Mil. Medigene AG did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Medigene AG Interest Expense Historical Data

The historical data trend for Medigene AG's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medigene AG Interest Expense Chart

Medigene AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-0.50

-0.52

-0.41

-0.70

-0.60

Medigene AG Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Interest Expense	Get a 7-Day Free Trial															-0.15	-0.55	-0.03	-0.57	-0.01

Medigene AG Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.58 Mil.

Medigene AG (OTCPK:MDGEF) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Medigene AG's Interest Expense for the six months ended in Jun. 2024 was $-0.01 Mil. Its Operating Income for the six months ended in Jun. 2024 was $-7.15 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Jun. 2024 was $1.73 Mil.

Medigene AG's Interest Coverage for the quarter that ended in Jun. 2024 is calculated as

Medigene AG did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Medigene AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medigene AG (OTCPK:MDGEF) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

0QGJ:UK MDG1:Germany MDG2:Austria

Address

Lochhamer Strasse 11, Martinsried, Planegg, BY, DEU, 82152

Website

https://www.medigene.com

Medigene AG is an immuno-oncology biotechnology company. focused on developing differentiated T Cell Receptor engineered T cell (TCR-T) therapies for the treatment of multiple solid tumor indications with a high unmet medical need. The operating segments of the organization are Immunotherapies and Other products. Immunotherapies consist of T-cell receptor-based adoptive T-cell therapy and DC vaccines. The group operates in the United States, Germany, and Asia, of which the majority of the revenue is derived from operations in Germany.